Search research articles
Contact Us
Filters
Showing results (231-240 of 248) with videos related to
Page
of 25
Sort By:
Nature Immunology
|
March 14, 2017
NLRP12 attenuates colon inflammation by maintaining colonic microbial diversity and promoting protective commensal bacterial growth
Liang Chen, Justin E Wilson, Mark J Koenigsknecht, et al.
Nature Immunology
|
October 19, 2017
Corrigendum: NLRP12 attenuates colon inflammation by maintaining colonic microbial diversity and promoting protective commensal bacterial growth
Liang Chen, Justin E Wilson, Mark J Koenigsknecht, et al.
ACS Medicinal Chemistry Letters
|
February 20, 2018
Synthesis of Novel Tetrahydroisoquinoline CXCR4 Antagonists with Rigidified Side-Chains
Edgars Jecs, Eric J Miller, Robert J Wilson, et al.
Cell Reports
|
August 18, 2021
Hypoxic preconditioning protects against ischemic kidney injury through the IDO1/kynurenine pathway
Rafael Torosyan, Shengping Huang, Prashant V Bommi, et al.
ACS Medicinal Chemistry Letters
|
June 18, 2014
Discovery of tetrahydroisoquinoline-based CXCR4 antagonists
Valarie M Truax, Huanyu Zhao, Brooke M Katzman, et al.
ACS Medicinal Chemistry Letters
|
May 26, 2018
Discovery of <i>N</i>-Alkyl Piperazine Side Chain Based CXCR4 Antagonists with Improved Drug-like Properties
Yesim A Tahirovic, Valarie M Truax, Robert J Wilson, et al.
ACS Medicinal Chemistry Letters
|
January 20, 2018
Synthesis and SAR of 1,2,3,4-Tetrahydroisoquinoline-Based CXCR4 Antagonists
Robert J Wilson, Edgars Jecs, Eric J Miller, et al.
Journal of Medicinal Chemistry
|
July 28, 2018
Design, Synthesis, and Pharmacological Evaluation of Second-Generation Tetrahydroisoquinoline-Based CXCR4 Antagonists with Favorable ADME Properties
Huy H Nguyen, Michelle B Kim, Robert J Wilson, et al.
Nature Communications
|
December 19, 2025
Synchronous mid-Holocene marine and terrestrial deglaciation in the Ross Sea, Antarctica
Rebecca L Parker, Christina R Riesselman, Olivia J Truax, et al.
Cancer Chemotherapy and Pharmacology
|
November 17, 2010
A phase I study of bevacizumab (B) in combination with everolimus (E) and erlotinib (E) in advanced cancer (BEE)
Karen E Bullock, William P Petros, Islam Younis, et al.
Page
of 25
Search research articles
Search
Showing results (231-240 of 248) with videos related to
Sort By:
Page
of 25
Nature Immunology
|
March 14, 2017
NLRP12 attenuates colon inflammation by maintaining colonic microbial diversity and promoting protective commensal bacterial growth
Liang Chen, Justin E Wilson, Mark J Koenigsknecht, et al.
Nature Immunology
|
October 19, 2017
Corrigendum: NLRP12 attenuates colon inflammation by maintaining colonic microbial diversity and promoting protective commensal bacterial growth
Liang Chen, Justin E Wilson, Mark J Koenigsknecht, et al.
ACS Medicinal Chemistry Letters
|
February 20, 2018
Synthesis of Novel Tetrahydroisoquinoline CXCR4 Antagonists with Rigidified Side-Chains
Edgars Jecs, Eric J Miller, Robert J Wilson, et al.
Cell Reports
|
August 18, 2021
Hypoxic preconditioning protects against ischemic kidney injury through the IDO1/kynurenine pathway
Rafael Torosyan, Shengping Huang, Prashant V Bommi, et al.
ACS Medicinal Chemistry Letters
|
June 18, 2014
Discovery of tetrahydroisoquinoline-based CXCR4 antagonists
Valarie M Truax, Huanyu Zhao, Brooke M Katzman, et al.
ACS Medicinal Chemistry Letters
|
May 26, 2018
Discovery of <i>N</i>-Alkyl Piperazine Side Chain Based CXCR4 Antagonists with Improved Drug-like Properties
Yesim A Tahirovic, Valarie M Truax, Robert J Wilson, et al.
ACS Medicinal Chemistry Letters
|
January 20, 2018
Synthesis and SAR of 1,2,3,4-Tetrahydroisoquinoline-Based CXCR4 Antagonists
Robert J Wilson, Edgars Jecs, Eric J Miller, et al.
Journal of Medicinal Chemistry
|
July 28, 2018
Design, Synthesis, and Pharmacological Evaluation of Second-Generation Tetrahydroisoquinoline-Based CXCR4 Antagonists with Favorable ADME Properties
Huy H Nguyen, Michelle B Kim, Robert J Wilson, et al.
Nature Communications
|
December 19, 2025
Synchronous mid-Holocene marine and terrestrial deglaciation in the Ross Sea, Antarctica
Rebecca L Parker, Christina R Riesselman, Olivia J Truax, et al.
Cancer Chemotherapy and Pharmacology
|
November 17, 2010
A phase I study of bevacizumab (B) in combination with everolimus (E) and erlotinib (E) in advanced cancer (BEE)
Karen E Bullock, William P Petros, Islam Younis, et al.
Page
of 25